Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Bococizumab

Bococizumab (USAN; development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the drug from development in November 2016, determining that it was "not likely to provide value to patients, physicians or shareholders."

Description, Clinical trials & Overview

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Research this topic

Explore the main themes, entities and connections around Bococizumab. Start with the topic map, then use the sections below for research and deeper semantic analysis.

Explore this topic

Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.

Description

3 related topics

Clinical trials

3 related topics

Overview

6 related topics

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

ATC code
none
CAS Number
1407495-02-6
ChEMBL
ChEMBL3137349
ChemSpider
none
Formula
C6414H9918N1722O2012S54
IUPHAR/BPS
7730

Topics to explore

Browse the full topic structure. Each item opens a new analysis centered on that subject.

Overview

Description

Clinical trials

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

Map overview Semantic statistics

Bococizumab

Nodes16
Edges15
Triples28
Avg. degree1.88
Density0.125
Components1

How this topic connects Entity context

See the strongest relationship patterns around the current topic before diving into the raw triples.

Bococizumab

Top relations

related to Clinical trials · 11
Bococizumab → After, American College, Cardiology, LDL, LDL-C, Monthly, Pfizer, SPIRE, The, The Phase, Wide
related to Description · 2
Bococizumab → LDL, PCSK9
ATC code · 1
Bococizumab → none
CAS Number · 1
Bococizumab → 1407495-02-6
ChEMBL · 1
Bococizumab → ChEMBL3137349
ChemSpider · 1
Bococizumab → none
Formula · 1
Bococizumab → C6414H9918N1722O2012S54
IUPHAR/BPS · 1
Bococizumab → 7730
KEGG · 1
Bococizumab → D10621 Y
Legal status · 1
Bococizumab → Investigational

Important terminology Word statistics

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

ldl development pfizer pcsk9 cholesterol drug code levels antibodies reduce patients trials antibody usan phase significantly anti-drug rn316 targeting withdrew

Entity relationships Subject–Predicate–Object triples

SubjectPredicateObjectConfidenceSrc
BococizumabATC codenone1.00infobox
BococizumabCAS Number1407495-02-61.00infobox
BococizumabChEMBLChEMBL31373491.00infobox
BococizumabChemSpidernone1.00infobox
BococizumabFormulaC6414H9918N1722O2012S541.00infobox
BococizumabIUPHAR/BPS77301.00infobox
BococizumabKEGGD10621 Y1.00infobox
BococizumabLegal statusInvestigational1.00infobox
BococizumabMolar mass145077.18 g·mol−11.00infobox
BococizumabPubChem SID1941685541.00infobox
BococizumabRoutes of administrationSubcutaneous injection1.00infobox
BococizumabSourceHumanized (from mouse)1.00infobox
BococizumabTargetProprotein convertase subtilisin/kexin type 9 (PCSK9)1.00infobox
BococizumabTypeWhole antibody1.00infobox
BococizumabUNII45M75JVK381.00infobox

Related concept clusters Concept neighborhoods

These clusters group vocabulary that occurs around closely connected concepts in the source material.

    Connections between topic areas Semantic bridges

    Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.

    Min side: 3
    For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.